Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Polydex Pharmaceuticals Limited

http://www.polydex.com

Latest From Polydex Pharmaceuticals Limited

Endo's microbicide gel fails to protect against HIV

Endo Pharmaceuticals' microbicide vaginal gel, PRO 2000 (naphthalene sulfonate polymer), intended for the prevention of HIV infection,has failed to show efficacy in a Phase III study involving more than 9,000 African women.

Infectious Diseases Gynecology & Urology

Indevus's microbicide gel shows encouraging signs of preventing HIV

Indevus Pharmaceuticals' PRO 2000 (naphthalene sulfonate polymer), the most advanced microbicide gel in development, has shown encouraging signs in preventing HIV infection in women in a study funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the US NIH. Meanwhile, ReProtect's BufferGel failed to show any signs of efficacy.

Immune Disorders Infectious Diseases
See All

Company Information

  • Industry
  • Distributors
  • Pharmaceuticals
  • Services
    • Services sold to health care facilities
  • Other Names / Subsidiaries
    • Chemdex
    • Dextran Products Limited
    • Polydex Chemicals Limited
UsernamePublicRestriction

Register